Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |